Back to Journals » Lung Cancer: Targets and Therapy
Lung Cancer: Targets and Therapy
Editor-in-Chief: Professor Sai-Hong Ignatius Ou
An international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (212)
- Volume 17, 2026 (4)
- Volume 16, 2025 (17)
- Volume 15, 2024 (19)
- Volume 14, 2023 (12)
- Volume 13, 2022 (8)
- Volume 12, 2021 (14)
- Volume 11, 2020 (11)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Latest articles:
- 5 records -
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
Liu SYM, Xie Z, Yan L, Jie GL, Deng JY, Zhang Q, Huang Z, Wang J, Zhang Z, Shao Y, Meng H, Zhang Y, Zhang XC, Chen HJ, Zhong WZ, Zhou Q, Wu YL
Lung Cancer: Targets and Therapy 2026, 17:596080
Published Date: 8 May 2026
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
Lumjiaktase P, Kemawichanurat N, Santiwiwas K, Kuttiyod T, Oranratnachai S, Trachu N, Monnamo N, Khiewngam K, Simmalee K, Reungwetwattana T
Lung Cancer: Targets and Therapy 2026, 17:578622
Published Date: 16 March 2026
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
Zhou J, Wang Y, Peng J, Tang KJ, Wu J, Chen Y, Xue Z, Wu YL
Lung Cancer: Targets and Therapy 2026, 17:555262
Published Date: 18 February 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer
Schraps N, Reck M, Hantzsch-Kuhn B, Olchers T, Ellebrecht DB, Möller K, Fraune C, Lennartz M, Lutz F, Kluth M, Makrypidi-Fraune G, Simon R, Sauter G, Steurer S, Von Weihe S
Lung Cancer: Targets and Therapy 2026, 17:530791
Published Date: 6 January 2026
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
Lee ATM, Park CJ, Arter ZL, Nagasaka M, Ou SHI
Lung Cancer: Targets and Therapy 2025, 16:199-203
Published Date: 25 December 2025